The Oncosearch | Oncotarget

Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer Research Paper

Jinjing Xia, Hao Bai, Bo Yan, Rong Li, Minhua Shao, Liwen Xiong, Baohui Han

Published Jul 20, 2017 · Vol. 8, No. 65 · pp. 108522-108533

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitorâ€“naïve patients with nonâ€“small cell lung cancer harboring EGFR mutations Research Paper

Kentaro Tanaka, Kaname Nosaki, Kohei Otsubo, Koichi Azuma, Shinya Sakata, Hiroshi Ouchi, Ryotaro Morinaga, Hiroshi Wataya, Akiko Fujii, Noriaki Nakagaki, Nobuko Tsuruta, Masafumi Takeshita, Eiji Iwama, Taishi Harada, Yoichi Nakanishi, Isamu Okamoto

Published Jul 12, 2017 · Vol. 8, No. 40 · pp. 68123-68130

Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome Research Paper

Thomas Kunzke, Benjamin Balluff, Annette Feuchtinger, Achim Buck, Rupert Langer, Birgit Luber, Florian Lordick, Horst Zitzelsberger, Michaela Aichler, Axel Walch

Published Jul 10, 2017 · Vol. 8, No. 40 · pp. 68012-68025

Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients Research Paper

Liwen Xiong, Shaohua Cui, Jingyan Ding, Yun Sun, Longfu Zhang, Yizhuo Zhao, Aiqin Gu, Tianqing Chu, Huimin Wang, Hua Zhong, Xin Ye, Yi Gu, Xin Zhang, Min Hu, Liyan Jiang

Published Jul 10, 2017 · Vol. 8, No. 38 · pp. 63846-63856

Comparison of direct sequencing and amplification refractory mutation system for detecting epidermal growth factor receptor mutation in non-small-cell lung cancer patients: a systematic review and meta-analysis Meta-Analysis

Qi Feng, Zu-Yao Yang, Jia-Tong Zhang, Jin-Ling Tang

Published Jul 8, 2017 · Vol. 8, No. 35 · pp. 59552-59562

Prognostic role of Gli1 expression in breast cancer: a meta-analysis Meta-Analysis

Bilan Wang, Ting Yu, Yuzhu Hu, Mengmeng Xiang, Haoning Peng, Yunzhu Lin, Lu Han, Lingli Zhang

Published Jul 7, 2017 · Vol. 8, No. 46 · pp. 81088-81097

Mammography and ultrasound effective features in differentiating basal-like and normal-like subtypes of triple negative breast cancer Clinical Research Papers

Zeng Zeng, Chun Jie Hou, Qiao Hong Hu, Ying Liu, Ceng Wang, Ran Wei, Xiao Ming Fan

Published Jul 6, 2017 · Vol. 8, No. 45 · pp. 79670-79679

Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib Research Paper

Nataliya Rohr-Udilova, Florian KlinglmÃ¼ller, Martha Seif, Hubert Hayden, Martin Bilban, Matthias Pinter, Klaus Stolze, Wolfgang Sieghart, Markus Peck-Radosavljevic, Michael Trauner

Published Jul 6, 2017 · Vol. 8, No. 34 · pp. 57109-57120

A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization Research Paper

Shanthi P. Kanthala, Yong-Yu Liu, Sitanshu Singh, Rushikesh Sable, Sandeep Pallerla, Seetharama D. Jois

Published Jul 5, 2017 · Vol. 8, No. 43 · pp. 74244-74262

HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer Priority Research Paper

Teru Hideshima, Ralph Mazitschek, Jun Qi, Naoya Mimura, Jen-Chieh Tseng, Andrew L. Kung, James E. Bradner, Kenneth C. Anderson

Published Jul 5, 2017 · Vol. 8, No. 46 · pp. 80109-80123

Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model Research Paper

Luisa Paris, Franca Podo, Francesca Spadaro, Laura Abalsamo, Maria Elena Pisanu, Alessandro Ricci, Serena Cecchetti, Luisa Altabella, Maria Buoncervello, Ludmila Lozneanu, Marina Bagnoli, Carlo Ramoni, Silvana Canevari, Delia Mezzanzanica, Egidio Iorio, Rossella Canese

Published Jul 5, 2017 · Vol. 8, No. 33 · pp. 55022-55038

Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer Review

Xuefei Li, Caicun Zhou

Published Jul 5, 2017 · Vol. 8, No. 59 · pp. 100801-100818

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer Research Paper

Xiaoping Wang, Monica E. Reyes, Dongwei Zhang, Yohei Funakoshi, Adriana P. Trape, Yun Gong, Takahiro Kogawa, Bedrich L. Eckhardt, Hiroko Masuda, David A. Pirman Jr, Peiying Yang, James M. Reuben, Wendy A. Woodward, Chandra Bartholomeusz, Gabriel N. Hortobagyi, Debu Tripathy, Naoto T. Ueno

Published Jul 4, 2017 · Vol. 8, No. 40 · pp. 67904-67917

The survival benefits of local surgery in stage IV breast cancer are not affected by breast cancer subtypes: a population-based analysis Research Paper

San-Gang Wu, Wen-Weng Zhang, Jia-Yuan Sun, Feng-Yan Li, Huan-Xin Lin, Juan Zhou, Zhen-Yu He

Published Jun 29, 2017 · Vol. 8, No. 40 · pp. 67851-67860

Epidermal growth factor receptor is associated with the onset of skeletal related events in non-small cell lung cancer Clinical Research Papers

Shu-Mei Huang, Jin-Ji Yang, Hua-Jun Chen, Si-Pei Wu, Xiao-Yan Bai, Qing Zhou, Hai-Yan Tu, Yi-Long Wu

Published Jun 28, 2017 · Vol. 8, No. 46 · pp. 81369-81376

Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers Research Paper

Ji Soo Choi, Dahye Yoon, Ja Seoug Koo, Siwon Kim, Vivian Youngjean Park, Eun-Kyung Kim, Suhkmann Kim, Min Jung Kim

Published Jun 28, 2017 · Vol. 8, No. 38 · pp. 63405-63416

Phenotypic and clinical characterization of low density neutrophils in patients with advanced lung adenocarcinoma Research Paper

Yangyang Liu, Yue Hu, Feifei Gu, Jinyan Liang, Yulan Zeng, Xiaohua Hong, Kai Zhang, Li Liu

Published Jun 28, 2017 · Vol. 8, No. 53 · pp. 90969-90978

The efficacy of 40 mg versus dose de-escalation to less than 40 mg of afatinib (Giotrif) as the first-line therapy for patients with primary lung adenocarcinoma harboring favorable epidermal growth factor mutations Clinical Research Papers

Chien-Ying Liu, Chih-Liang Wang, Shih-Hong Li, Ping-Chih Hsu, Chih-Hung Chen, Ting-Yu Lin, Chih-Hsi Kuo, Yueh-Fu Fang, How-Wen Ko, Chih-Teng Yu, Tai-Yun Yang, Cheng-Ta Yang

Published Jun 27, 2017 · Vol. 8, No. 57 · pp. 97602-97612

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway Research Paper

Jingwei Shao, Guirong Zheng, Hongning Chen, Jian Liu, Aixiao Xu, Fan Chen, Tao Li, Yusheng Lu, Jianguo Xu, Ning Zheng, Lee Jia

Published Jun 27, 2017 · Vol. 8, No. 45 · pp. 78351-78364

Cell-specific regulation of proliferation by Ano1/TMEM16A in breast cancer with different ER, PR, and HER2 status Research Paper

Huizhe Wu, Hui Wang, Shu Guan, Jing Zhang, Qiuchen Chen, Xiaodong Wang, Ke Ma, Pengfei Zhao, Haishan Zhao, Weifan Yao, Feng Jin, Qinghuan Xiao, Minjie Wei

Published Jun 27, 2017 · Vol. 8, No. 49 · pp. 84996-85013

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer Research Paper

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitorâ€“naïve patients with nonâ€“small cell lung cancer harboring EGFR mutations Research Paper

Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome Research Paper

Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients Research Paper

Comparison of direct sequencing and amplification refractory mutation system for detecting epidermal growth factor receptor mutation in non-small-cell lung cancer patients: a systematic review and meta-analysis Meta-Analysis

Prognostic role of Gli1 expression in breast cancer: a meta-analysis Meta-Analysis

Mammography and ultrasound effective features in differentiating basal-like and normal-like subtypes of triple negative breast cancer Clinical Research Papers

Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib Research Paper

A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization Research Paper

HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer Priority Research Paper

Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model Research Paper

Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer Review

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer Research Paper

The survival benefits of local surgery in stage IV breast cancer are not affected by breast cancer subtypes: a population-based analysis Research Paper

Epidermal growth factor receptor is associated with the onset of skeletal related events in non-small cell lung cancer Clinical Research Papers

Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers Research Paper

Phenotypic and clinical characterization of low density neutrophils in patients with advanced lung adenocarcinoma Research Paper

The efficacy of 40 mg versus dose de-escalation to less than 40 mg of afatinib (Giotrif) as the first-line therapy for patients with primary lung adenocarcinoma harboring favorable epidermal growth factor mutations Clinical Research Papers

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway Research Paper

Cell-specific regulation of proliferation by Ano1/TMEM16A in breast cancer with different ER, PR, and HER2 status Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer Research Paper

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitorâ€“naïve patients with nonâ€“small cell lung cancer harboring EGFR mutations Research Paper

Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome Research Paper

Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients Research Paper

Comparison of direct sequencing and amplification refractory mutation system for detecting epidermal growth factor receptor mutation in non-small-cell lung cancer patients: a systematic review and meta-analysis Meta-Analysis

Prognostic role of Gli1 expression in breast cancer: a meta-analysis Meta-Analysis

Mammography and ultrasound effective features in differentiating basal-like and normal-like subtypes of triple negative breast cancer Clinical Research Papers

Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib Research Paper

A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization Research Paper

HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer Priority Research Paper

Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model Research Paper

Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer Review

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer Research Paper

The survival benefits of local surgery in stage IV breast cancer are not affected by breast cancer subtypes: a population-based analysis Research Paper

Epidermal growth factor receptor is associated with the onset of skeletal related events in non-small cell lung cancer Clinical Research Papers

Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers Research Paper

Phenotypic and clinical characterization of low density neutrophils in patients with advanced lung adenocarcinoma Research Paper

The efficacy of 40 mg versus dose de-escalation to less than 40 mg of afatinib (Giotrif) as the first-line therapy for patients with primary lung adenocarcinoma harboring favorable epidermal growth factor mutations Clinical Research Papers

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway Research Paper

Cell-specific regulation of proliferation by Ano1/TMEM16A in breast cancer with different ER, PR, and HER2 status Research Paper